In Brief: Fountain Pharmaceuticals
This article was originally published in The Tan Sheet
Executive Summary
Fountain Pharmaceuticals: Has entered into a long-term licensing and supply agreement with Dermik Labs for products using Fountain's encapsulation delivery system, the company announced Jan. 19. Collegetown, Penn.-based Dermik, a subsidiary of Rhone-Poulenc Rorer, currently markets Hytone hydrocortisone cream, Zetar coal tar shampoo, and Shepard's cream lotion, while Fountain is mostly involved in moisturizers and sunscreens. The companies plan to begin introducing new products domestically and internationally within the next few months under the agreement...